Numinus Wellness Inc. Reports Q4 2022 and Annual Results Post published:December 2, 2022 Post category:Press Release
PsyBio Therapeutics Announces Non-Brokered Private Placement Financing Post published:December 1, 2022 Post category:Press Release
FILAMENT HEALTH ANNOUNCES NEW UNITED STATES PATENT ISSUANCES Post published:December 1, 2022 Post category:Press Release
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine Post published:December 1, 2022 Post category:Press Release
Revive Therapeutics Ltd. Announces Offering of Up to $5 Million Post published:December 1, 2022 Post category:Press Release
Clearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical Trial Post published:December 1, 2022 Post category:Press Release
Small Pharma to Participate in November Investor and Healthcare Conferences Post published:November 29, 2022 Post category:Press Release
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America Post published:November 29, 2022 Post category:Press Release
Silo Pharma Initiates Study of Novel Joint Homing Peptide in Human Tissue Post published:November 29, 2022 Post category:Press Release
Tryp Therapeutics Announces Poster Presentations on the Reduction of Chronic Pain in a Rodent Model with Psilocybin and Intravenous Psilocybin Alters Brain Network Dynamics in Rats at the 2022 Society for Neuroscience Conference Post published:November 29, 2022 Post category:Press Release